Last reviewed · How we verify
NCT05667545
Evaluation of the Effect of Self-Assembling Peptide P11-4
Phase 1 trial testing Peptide in Dental Caries in 30 participants. Completed in 30 October 2021.
1 October 2021
Quick facts
| Lead sponsor | Egymedicalpedia |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 July 2021 |
| Primary completion | 1 October 2021 |
| Estimated completion | 30 October 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Peptide — full drug profile →
Conditions studied
- Dental Caries — all drugs for Dental Caries →
Sponsor
Egymedicalpedia — full company profile →
Who can join
Adults 18 to 30, any sex, with Dental Caries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dental caries is a biofilm-mediated, sugar-driven, multifactorial, dynamic disease that results in the phasic demineralization and remineralization of dental hard tissues. These tissues have poor regeneration capability because of the lack of both regenerative cells and vascularization. In the complex caries progression process involving dietary sugars, bacterial metabolism and demineralization, the collagenous organic matrix becomes exposed and destroyed by resident and bacterial proteases, allowing the lesion to expand
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05667545
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Peptide
Trials testing the same drug.
- NCT04072900 — A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma · Phase 1 · unknown
Other recruiting trials for Dental Caries
Currently open trials in the same condition.
- NCT06787261 — Involvement of Archaea in Carious Disease · NA · recruiting
- NCT06753669 — Mothers' Action Project for Child Health · NA · recruiting
- NCT07431463 — Effects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary T · NA · active not recruiting
- NCT07134114 — Occlusal Impact of Hall Crowns in Primary Molars · NA · recruiting
- NCT07181967 — SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children · NA · recruiting
Other Egymedicalpedia trials
Trials by the same sponsor.
- NCT06590818 — The Effect of Body Mass Index on Short-term Results of HTO · NA · recruiting
- NCT06583811 — Remifentanil and Remimazolam to Limit Patient Movement · NA · recruiting
- NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting
- NCT06370078 — Effect of Early Administration of Albumin 20% Versus Crystalloid · NA · recruiting
- NCT06370221 — The Effect of Psoriatic Arthritis on Female Sexual Dysfunction · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05667545 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Egymedicalpedia
- Last refreshed: 6 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05667545.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing